annual EBITDA:
-$436.83M+$128.64M(+22.75%)Summary
- As of today (June 2, 2025), BBIO annual EBITDA is -$436.83 million, with the most recent change of +$128.64 million (+22.75%) on December 31, 2024.
- During the last 3 years, BBIO annual EBITDA has risen by +$97.00 million (+18.17%).
- BBIO annual EBITDA is now -896.89% below its all-time high of -$43.82 million, reached on December 31, 2017.
Performance
BBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$126.18M+$108.86M(+46.32%)Summary
- As of today (June 2, 2025), BBIO quarterly EBITDA is -$126.18 million, with the most recent change of +$108.86 million (+46.32%) on March 31, 2025.
- Over the past year, BBIO quarterly EBITDA has dropped by -$115.09 million (-1037.50%).
- BBIO quarterly EBITDA is now -753.73% below its all-time high of $19.30 million, reached on June 30, 2022.
Performance
BBIO quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$551.92M-$115.09M(-26.35%)Summary
- As of today (June 2, 2025), BBIO TTM EBITDA is -$551.92 million, with the most recent change of -$115.09 million (-26.35%) on March 31, 2025.
- Over the past year, BBIO TTM EBITDA has dropped by -$96.34 million (-21.15%).
- BBIO TTM EBITDA is now -1201.79% below its all-time high of -$42.40 million, reached on March 31, 2018.
Performance
BBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BBIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.8% | -1037.5% | -21.1% |
| 3 y3 years | +18.2% | +29.6% | +0.0% |
| 5 y5 years | -56.6% | -26.8% | -77.1% |
BBIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.9% | +22.8% | -753.7% | +46.3% | -62.6% | +2.4% |
| 5 y | 5-year | -56.6% | +22.8% | -753.7% | +46.3% | -77.1% | +2.4% |
| alltime | all time | -896.9% | +22.8% | -753.7% | +46.3% | -1201.8% | +2.4% |
BBIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$126.18M(-46.3%) | -$551.92M(+26.3%) |
| Dec 2024 | -$436.83M(-22.7%) | -$235.05M(+68.3%) | -$436.83M(+24.7%) |
| Sep 2024 | - | -$139.66M(+173.7%) | -$350.26M(-4.9%) |
| Jun 2024 | - | -$51.03M(+360.0%) | -$368.14M(-19.2%) |
| Mar 2024 | - | -$11.09M(-92.5%) | -$455.58M(-19.4%) |
| Dec 2023 | -$565.47M(+42.3%) | -$148.47M(-5.8%) | -$565.47M(+5.5%) |
| Sep 2023 | - | -$157.54M(+13.8%) | -$535.91M(+7.8%) |
| Jun 2023 | - | -$138.47M(+14.5%) | -$497.09M(+46.5%) |
| Mar 2023 | - | -$120.98M(+1.7%) | -$339.32M(-14.6%) |
| Dec 2022 | -$397.44M(-25.5%) | -$118.92M(+0.2%) | -$397.44M(-4.0%) |
| Sep 2022 | - | -$118.72M(-715.1%) | -$414.14M(-7.0%) |
| Jun 2022 | - | $19.30M(-110.8%) | -$445.11M(-19.4%) |
| Mar 2022 | - | -$179.10M(+32.1%) | -$552.16M(+3.4%) |
| Dec 2021 | -$533.83M | -$135.62M(-9.4%) | -$533.83M(+2.3%) |
| Sep 2021 | - | -$149.68M(+70.6%) | -$521.84M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$87.75M(-45.4%) | -$491.39M(-6.9%) |
| Mar 2021 | - | -$160.78M(+30.0%) | -$527.61M(+13.1%) |
| Dec 2020 | -$467.38M(+67.5%) | -$123.63M(+3.7%) | -$466.36M(+10.0%) |
| Sep 2020 | - | -$119.24M(-3.8%) | -$423.85M(+16.7%) |
| Jun 2020 | - | -$123.97M(+24.5%) | -$363.16M(+16.6%) |
| Mar 2020 | - | -$99.53M(+22.7%) | -$311.59M(+11.4%) |
| Dec 2019 | -$278.96M(+67.1%) | -$81.11M(+38.5%) | -$279.82M(+13.4%) |
| Sep 2019 | - | -$58.55M(-19.1%) | -$246.77M(+7.7%) |
| Jun 2019 | - | -$72.39M(+6.8%) | -$229.06M(+19.2%) |
| Mar 2019 | - | -$67.77M(+41.0%) | -$192.13M(+15.2%) |
| Dec 2018 | -$166.90M(+280.9%) | -$48.06M(+17.7%) | -$166.76M(+40.5%) |
| Sep 2018 | - | -$40.84M(+15.2%) | -$118.70M(+52.5%) |
| Jun 2018 | - | -$35.45M(-16.4%) | -$77.85M(+83.6%) |
| Mar 2018 | - | -$42.40M | -$42.40M |
| Dec 2017 | -$43.82M | - | - |
FAQ
- What is BridgeBio Pharma annual EBITDA?
- What is the all time high annual EBITDA for BridgeBio Pharma?
- What is BridgeBio Pharma annual EBITDA year-on-year change?
- What is BridgeBio Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly EBITDA year-on-year change?
- What is BridgeBio Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for BridgeBio Pharma?
- What is BridgeBio Pharma TTM EBITDA year-on-year change?
What is BridgeBio Pharma annual EBITDA?
The current annual EBITDA of BBIO is -$436.83M
What is the all time high annual EBITDA for BridgeBio Pharma?
BridgeBio Pharma all-time high annual EBITDA is -$43.82M
What is BridgeBio Pharma annual EBITDA year-on-year change?
Over the past year, BBIO annual EBITDA has changed by +$128.64M (+22.75%)
What is BridgeBio Pharma quarterly EBITDA?
The current quarterly EBITDA of BBIO is -$126.18M
What is the all time high quarterly EBITDA for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly EBITDA is $19.30M
What is BridgeBio Pharma quarterly EBITDA year-on-year change?
Over the past year, BBIO quarterly EBITDA has changed by -$115.09M (-1037.50%)
What is BridgeBio Pharma TTM EBITDA?
The current TTM EBITDA of BBIO is -$551.92M
What is the all time high TTM EBITDA for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM EBITDA is -$42.40M
What is BridgeBio Pharma TTM EBITDA year-on-year change?
Over the past year, BBIO TTM EBITDA has changed by -$96.34M (-21.15%)